5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 3.10▼ | 3.09▼ | 3.10▼ | 3.12▼ | 3.39▼ |
MA10 | 3.10▼ | 3.08▲ | 3.09▼ | 3.19▼ | 3.88▼ |
MA20 | 3.10▼ | 3.10▼ | 3.13▼ | 3.39▼ | 4.45▼ |
MA50 | 3.08▲ | 3.12▼ | 3.11▼ | 4.07▼ | 3.91▼ |
MA100 | 3.10▼ | 3.13▼ | 3.31▼ | 4.48▼ | 2.82▲ |
MA200 | 3.14▼ | 3.33▼ | 3.55▼ | 3.91▼ | 2.73▲ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.001▼ | 0.003▲ | -0.003▼ | 0.010▲ | -0.258▼ |
RSI | 47.574▼ | 46.947▼ | 45.873▼ | 34.746▼ | 38.661▼ |
STOCH | 43.519 | 64.263 | 37.399 | 18.878▼ | 6.186▼ |
WILL %R | -66.667 | -54.545 | -79.167▼ | -83.133▼ | -95.070▼ |
CCI | -70.707 | 68.331 | -34.343 | -73.254 | -110.263▼ |
Friday, January 17, 2025 09:32 PM
Aquestive Therapeutics, Inc. (NASDAQ:AQST – Get Free Report) has earned an average rating of “Buy” from the seven analysts that are covering the company, MarketBeat.com reports. Six analysts have ...
|
Friday, January 17, 2025 09:32 PM
Aquestive Therapeutics, Inc. (NASDAQ:AQST – Get Free Report) has earned an average rating of “Buy” from the seven analysts that are covering the company, MarketBeat.com reports. Six analysts have ...
|
Friday, January 17, 2025 01:00 PM
Aquestive Therapeutics (NASDAQ: NASDAQ:AQST) reported a strong financial performance in its Q3 2023 earnings call, with CEO Dan Barber and CFO Ernie Toth highlighting ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
17/01/25 | 3.10 | 3.14 | 3.04 | 3.10 | 1,163,397 |
16/01/25 | 3.25 | 3.30 | 3.08 | 3.09 | 1,441,268 |
15/01/25 | 3.12 | 3.25 | 3.0622 | 3.24 | 1,245,820 |
14/01/25 | 3.14 | 3.275 | 3.01 | 3.05 | 1,553,571 |
13/01/25 | 3.08 | 3.155 | 2.96 | 3.11 | 1,091,231 |
10/01/25 | 3.09 | 3.10 | 2.98 | 3.08 | 1,946,832 |
08/01/25 | 3.22 | 3.25 | 3.065 | 3.13 | 2,194,641 |
07/01/25 | 3.275 | 3.41 | 3.195 | 3.24 | 3,226,890 |
06/01/25 | 3.58 | 3.59 | 3.26 | 3.30 | 2,555,273 |
03/01/25 | 3.69 | 3.77 | 3.57 | 3.58 | 893,203 |
|
|
||||
|
|
||||
|
|